Abnormal cognitive aging in people with HIV: evidence from data integration between two countries' cohort studies
- PMID: 35471252
- DOI: 10.1097/QAD.0000000000003230
Abnormal cognitive aging in people with HIV: evidence from data integration between two countries' cohort studies
Abstract
Objectives: Previous research has shown inconsistent results on whether cognitive aging is abnormal in people with HIV (PWH) because of low sample size, cross-sectional design, and nonstandard neuropsychological methods. To address these issues, we integrated data from two longitudinal studies: Australian HIV and Brain Ageing Research Program ( N = 102) and CNS HIV Antiretroviral Therapy Effects Research (CHARTER) study ( N = 924) and determined the effect of abnormal aging on neurocognitive impairment (NCI) among PWH.
Methods: Both studies used the same neuropsychological test battery. NCI was defined based on demographically corrected global deficit score (≥0.5 = impaired). Both studies also assessed comorbidities, neuropsychiatric conditions and functional status using similar tools. To determine the cross-sectional and longitudinal effects of age on the risk of NCI, a generalized linear mixed-effect model tested main and interaction effects of age group (young, <50 vs. old, ≥50) and time on NCI adjusting the effects of covariates.
Results: Older PWH had 83% higher chance of NCI compared with younger PWH [odds ratio (OR) = 1.83 (1.15-2.90), P < 0.05]. Older participants also had a greater risk of increases in NCI over the follow-up [OR = 1.66 (1.05-2.64), P < 0.05] than younger participants. Nonwhite ethnicity ( P < 0.05), having a contributing ( P < 0.05) or confounding ( P < 0.001) comorbidity, greater cognitive symptoms ( P < 0.001), and abnormal creatinine level ( P < 0.05), plasma viral load greater than 200 copies/ml ( P < 0.05), being from the Australian cohort ( P < 0.05) were also associated with a higher risk of NCI.
Conclusion: Data integration may serve as a strategy to increase sample size and study power to better assess abnormal cognitive aging effect in PWH, which was significant in the current study.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
References
-
- Aung HL, Kootar S, Gates TM, Brew BJ, Cysique LA. How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection? . Eur Geriatr Med 2019; 10:227–238.
-
- Cysique LA, Brew BJ. The effects of HIV and aging on brain functions: proposing a research framework and update on last 3 years’ findings . Curr Opin HIV AIDS 2014; 9:355–364.
-
- Aung HL, Cysique LA. What is the level of evidence for premature and accelerated aging effects on neurocognition in people living with HIV? A systematic review and meta-analysis. In: PROSPERO , 2019.
-
- Stephan BCM, Siervo M, Brayne C. How can population-based studies best be utilized to reduce the global impact of dementia? Recommendations for researchers, funders, and policymakers . Alzheimers Dement 2020; 16:1448–1456.
-
- Brodaty H, Woolf C, Andersen S, Barzilai N, Brayne C, Cheung KS-L, et al. ICC-dementia (International Centenarian Consortium-dementia): an international consortium to determine the prevalence and incidence of dementia in centenarians across diverse ethnoracial and sociocultural groups . BMC Neurol 2016; 16:1–10.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
